MARKET

ALZN

ALZN

Alzamend Neuro Inc
NASDAQ
1.680
+0.020
+1.20%
After Hours: 1.560 -0.12 -7.13% 16:59 09/08 EDT
OPEN
1.660
PREV CLOSE
1.660
HIGH
1.717
LOW
1.620
VOLUME
31.19K
TURNOVER
--
52 WEEK HIGH
2.680
52 WEEK LOW
0.8400
MARKET CAP
8.11M
P/E (TTM)
-0.6391
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALZN last week (0831-0904)?
Weekly Report · 1d ago
Weekly Report: what happened at ALZN last week (0824-0828)?
Weekly Report · 08/31 09:55
Weekly Report: what happened at ALZN last week (0817-0821)?
Weekly Report · 08/24 09:56
Alzamend Neuro Files Prospectus Related To The Resale Of Up To 98.4M Common Shares By Selling Stockholder
Benzinga · 08/21 20:51
Alzamend Neuro registers to sell 98.39M shares of common stock for holders
TipRanks · 08/21 20:35
Alzamend Neuro Announces Its Abstract On Resting-State Functional Magnetic Resonance Imaging Findings For AL001 Accepted For Presentation At Neuroscience 2026
Benzinga · 08/20 12:08
Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga · 08/19 12:23
Alzamend Neuro Price Target Raised to $26.00/Share From $25.00 by Ascendiant Capital
Dow Jones · 08/19 10:16
More
About ALZN
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and L-proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment. ALZN002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer's by removing beta-amyloid from the brain through a royalty-bearing exclusive worldwide license from the Licensor.

Webull offers Alzamend Neuro Inc stock information, including NASDAQ: ALZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALZN stock methods without spending real money on the virtual paper trading platform.